Guardian Research Network Inc. announced that Bergen New Bridge Medical Center, New Jersey’s largest hospital and a clinical affiliate of Rutgers University Medical School, has joined its nationwide healthcare system research network. As not-for-profits, both entities come together to bring healthcare innovation to local communities and enhance patient diversity in a focus on improved healthcare.
Also Read: DAB.bio’s Turbocharged Fermenter Reduces Biomanufacturing Costs by 50%
The strategic relationship will contribute to GRN’s mission of translating data into cures and providing research answers for improved health. The alliance will enable GRN to extend beyond its cancer roots and into diabetes, rare diseases, mental health, and other illnesses as Bergen New Bridge is also the nation’s fourth largest publicly-owned hospital.
Bergen New Bridge will be embarking on cutting-edge diagnostic studies in communities that do not traditionally seek healthcare early. “We can help identify cancers and other diseases earlier to eventually improve treatment outcomes,” says Bergen New Bridge President and CEO, Deborah Visconi. “This aligns with our mission to bring true population health and access to healthcare at critical early stages to underrepresented populations across the county.”
Representing millions of patients across the country, GRN focuses on advancing healthcare data technology, clinical research trials, and real-world data science.
“We are thrilled to partner with Bergen New Bridge Medical Center,” says Bruce Holstien, Chairman and CEO, GRN. “Bergen’s excellent reputation, expert medical services, and clinical innovations overlayed by their mission to serve all, are a perfect match for the Guardian Research Network. Our collective efforts to democratize clinical trials, accelerate cures for disease, and develop the core medical data research engine for the coming decade are further enhanced by Bergen’s entry into our now 25+ state-represented network of health systems.”
GRN, a non-profit organization, is a nationwide health system research consortium focused on advancing technology to accelerate cures for life-threatening diseases such as cancer. GRN works with life sciences clients and health system members to increase participation in data-driven clinical trials, optimize therapeutic and diagnostic studies, and employ real-world data to improve patient access to precision medicines in under-served communities.